MedPath

Aminocaproic acid

Aminocaproic Acid Tablets, USP (500 mg) Rx only

Approved
Approval ID

4a22e559-2dac-42d7-af8d-eb0ebbc2f76d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 29, 2023

Manufacturers
FDA

Amneal Pharmaceuticals NY LLC

DUNS: 123797875

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Aminocaproic acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69238-1637
Application NumberANDA212492
Product Classification
M
Marketing Category
C73584
G
Generic Name
Aminocaproic acid
Product Specifications
Route of AdministrationORAL
Effective DateDecember 29, 2023
FDA Product Classification

INGREDIENTS (5)

AMINOCAPROIC ACIDActive
Quantity: 500 mg in 1 1
Code: U6F3787206
Classification: ACTIB
CROSPOVIDONE (15 MPA.S AT 5%)Inactive
Code: 68401960MK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.